Full name
ICB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
ICB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
UL. STANISŁAWA LEMA 10, 43-603 JAWORZNO
TAX ID6322019698
Rate company:
ICB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
TAX ID6322019698
KRS0000723952
address
UL. STANISŁAWA LEMA 10, 43-603 JAWORZNO
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
Company removed from KRS 3 Mar 2025 y.
NIP
6322019698
REGON
369775548
KRS
0000723952
Legal form
limited liability company
Register Address
UL. STANISŁAWA LEMA 10, 43-603 JAWORZNO
Date of registration in KRS
2018-03-23
Date of commencement of economic activity
2018-03-23
Act signature
KA.VIII NS-REJ.KRS/6608/24/254
Pkd codes
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.20.Z - Manufacture of pesticides and other agrochemical products
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
64.20.Z - Activities of holding companies
82.11.Z - Office administrative service activities
82.19.Z - Photocopying, document preparation and other specialised office support activities
82.99.Z - Other business support service activities not elsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
Payer VAT status
Unregirestered
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2018 | 2019 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss)  | -5,5 | -0,1 | 97,5 |
EBITDA | -5,5 | -0,1 | 97,5 |
Short time liabilities | 1,5 | 1,5 | -3,7 |
Equity capital | 4,5 | 4,4 | -3 |
Operating profit (EBIT) | -5,5 | -0,1 | 97,5 |
Assets | 6,1 | 5,9 | -3,1 |
Net profit (loss) | -5,5 | -0,1 | 97,5 |
Cash | 4,9 | 3,7 | -23,7 |
Net income from sale | 0 | 10 | -∞ |
Liabilities and provisions for liabilities | 1,5 | 1,5 | -3,7 |
Working assets | 6,1 | 5,9 | -3,1 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -119,8 | -3 | 116,8 |
Equity capital to total assets | 74,7 | 74,9 | 0,2 |
Gross profit margin | -1,3 | ||
EBITDA Margin | -1,3 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 54 | -2 147 483 594 |
Current financial liquidity indicator | 3.958653688430786 | 3.9829256534576416 | 0 |
Net dept to EBITDA | 0.8989883065223694 | 27.859390258789062 | 27 |
Financial statements
22-09-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download xades22-09-2022 - 31-12-2022
Annual financial report
Download xml22-09-2022 - 31-12-2022
Annual financial report
Download pdf22-09-2022 - 31-12-2022
Activity report
Download xadesShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
WGW WATER SOLUTION KRZYSZTOF WYSZYŃSKI
Nowe Załubice
Robert Pawlak
Ostrów Wielkopolski
Alvana Andrzej Kałamarz
Opole
Piotr Latos Nanochem
Gliwice
Softel - Eliasz Kętrzyński
Warszawa